Related Experiment Video
Updated: Feb 23, 2026

Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
Published on: January 23, 2018
Advances in Ankle Cartilage Repair
Alan Ng1, Andrew Bernhard2, Kaitlyn Bernhard3
1PMSR/RRA, Highlands/Presbyterian St. Luke's Podiatric Surgical Residency Program, 1719 East 19th Avenue, Denver, CO 80218, USA; Private Practice, Advanced Orthopedic and Sports Medicine Specialists, 8101 East Lowry Boulevard #230, Denver, CO 80230, USA.
Treating osteochondral lesions of the talus is challenging. Promising results are seen with autologous chondrocyte implantation for intermediate lesions, with future research focusing on new therapies and observational studies.
Area of Science:
- Orthopedic surgery
- Regenerative medicine
- Sports medicine
Background:
- Osteochondral lesions of the talus present a significant clinical challenge.
- Treatment difficulty varies with lesion size, with small lesions amenable to arthroscopic techniques and large lesions often requiring fusion or replacement.
Purpose of the Study:
- To review current and emerging treatment modalities for osteochondral lesions of the talus.
- To highlight the efficacy of cell-based therapies for intermediate-sized lesions.
- To suggest future research directions in the field.
Main Methods:
- Review of existing literature on talar osteochondral lesion treatment.
- Discussion of arthroscopy, microfracture, allograft replacement, ankle fusion, autologous chondrocyte implantation (ACI), and matrix-associated autologous chondrocyte implantation (MACI).
- Consideration of future research methodologies, including prospective observational studies.
Main Results:
- Arthroscopy and microfracture are effective for smaller lesions.
- Larger cystic lesions often necessitate talus replacement or ankle fusion.
- Autologous chondrocyte implantation and matrix-associated autologous chondrocyte implantation show promise for intermediate lesions.
- Arthroscopic implantation techniques are demonstrated.
Conclusions:
- A spectrum of treatments exists for talar osteochondral lesions, tailored to lesion size.
- Cell-based therapies like ACI and MACI represent a viable option for challenging intermediate lesions.
- Future research should prioritize prospective observational studies and explore novel pharmacologic and cell-based interventions.
More Related Videos
11:22Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
09:01Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach
Published on: January 24, 2018
Related Concept Videos
Growth of Cartilage and Bone Tissue
Ankle Joint